Last updated 11 days ago

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

927 patients around the world
Available in Chile, United States
Amgen
1Research sites
927Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
To 99 Years
All Gender
Medical requirements
Sites
Centro Oncológico y Tratamiento Oncología - CDIEM
Recruiting
María Luisa Santander 485, 7500859 Providencia, Región Metropolitana, Chile
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy